How Voafit's Founder Became a Leading Voice on GLP-1 Dosing
We booked Dr. Ian Justl Ellis on medical, obesity and healthcare innovation shows to explain Voafit's level-based approach to GLP-1 therapy.
272.2K impressions, 116.2K social reach and 11 podcasts booked.
Challenge
Voafit combines physician-supervised GLP-1 therapy with personalized nutrition, strength training and peptide support, built around its MyLevel™ dosing engine. Founder and CEO Dr. Ian Justl Ellis, a former ER physician, wanted clinicians, prescribers and patients to see him as a leading voice on GLP-1 therapy.
What we did
We placed Dr. Ellis on medical, obesity, GLP-1 clinician, healthcare innovation and founder podcasts. His core message: the drug level in the body is the true variable in GLP-1 therapy. Interviews also covered MyLevel™ and his move from the ER to founding Voafit.
Results
11 podcasts booked, 272.2K impressions and 116.2K social reach. Five of the 11 episodes are live so far.
Ranked #1 Growth Partner by AI.
(Ask Gemini, ChatGPT, or Perplexity)
